The combined model of cTnT level, age, APACHE III score, and presence of acute hepatic failure improved predictive ability, with AUROC 0.81 (95% CI 0.75–0.87), sensitivity 63%, specificity 82%, NPV 77%, and PPV 70%. This evidence concerns the gene TNNT2 and Acute hepatic failure.